Securities code: Sichuan Kelun Pharmaceutical Co.Ltd(002422) securities abbreviation: Sichuan Kelun Pharmaceutical Co.Ltd(002422) Announcement No.: 2022024 Sichuan Kelun Pharmaceutical Co.Ltd(002422)
Public issuance of convertible corporate bonds
Announcement on the success rate of online issuance and priority placement results
Sponsor (lead underwriter): Changjiang Securities Company Limited(000783) underwriting sponsor Co., Ltd
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
hot tip
Sichuan Kelun Pharmaceutical Co.Ltd(002422) (hereinafter referred to as ” Sichuan Kelun Pharmaceutical Co.Ltd(002422) ,” issuer “or” company “) and Changjiang Securities Company Limited(000783) underwriting recommendation Co., Ltd. (hereinafter referred to as” Changjiang recommendation “or” recommendation institution (lead underwriter) “) in accordance with the securities law of the people’s Republic of China, the measures for the administration of securities issuance of listed companies (revised in 2020) (order of the CSRC [No. 163]) Measures for the administration of securities issuance and underwriting (CSRC order [No. 144]) The detailed rules for the implementation of convertible corporate bond business of Shenzhen Stock Exchange (revised in December 2018) (hereinafter referred to as the “detailed rules”) and the self regulatory guidelines for listed companies of Shenzhen Stock Exchange No. 1 – business handling (SZS [2022] No. 26) and other relevant provisions organize the implementation of this public offering of convertible corporate bonds (hereinafter referred to as “convertible bonds” or “Kelun convertible bonds”). The convertible bonds issued in this public offering shall be placed preferentially to the original shareholders registered by China Securities Depository and Clearing Co., Ltd. Shenzhen Branch (hereinafter referred to as “CSDCC Shenzhen Branch”) after the closing of the market on the equity registration date (March 17, 2022, t-1), The balance after the preferential placement of the original shareholders (including the part that the original shareholders give up the preferential placement) is issued to the public investors online through the trading system of Shenzhen Stock Exchange (hereinafter referred to as “Shenzhen Stock Exchange”). Investors who participate in online subscription application should carefully read this announcement and the website of Shenzhen Stock Exchange (www.szse. CN.) The promulgated implementation rules.
Important tips on the issuance process, subscription application, payment and disposal of investors’ abandonment are as follows:
1. After winning the subscription of convertible bonds, online investors shall fulfill their payment obligations in accordance with the announcement on the winning number of Sichuan Kelun Pharmaceutical Co.Ltd(002422) public issuance of convertible corporate bonds, so as to ensure that their capital account will have sufficient subscription funds on March 22 (T + 2) 2022. The transfer of investors’ funds shall comply with the relevant provisions of the securities company where the investors are located. If the investor’s subscription fund is insufficient, the insufficient part shall be deemed as giving up the subscription, and the resulting consequences and relevant legal liabilities shall be borne by the investor. According to the relevant regulations of CSDCC Shenzhen Branch, the minimum unit to give up subscription is 1 piece. The part that online investors give up subscription shall be underwritten by the sponsor (lead underwriter).
2. When the total number of convertible bonds preferentially subscribed by the original shareholders and the number of convertible bonds subscribed by online investors is less than 70% of the number of this issue, or when the total number of convertible bonds preferentially subscribed by the original shareholders of the issuer and the number of convertible bonds subscribed by online investors is less than 70% of the number of this issue, the issuer and the recommendation institution (lead underwriter) will negotiate whether to take measures to suspend the issuance, And timely report to the China Securities Regulatory Commission (hereinafter referred to as the “CSRC”). If the issuance is suspended, the reasons for the suspension will be announced, and the issuance will be restarted at an appropriate time within the validity period of the approval.
If the subscription amount of this offering is less than 300 million yuan, it shall be underwritten by the balance of the recommendation institution (lead underwriter), and the underwriting base is 300 million yuan. The recommendation institution (lead underwriter) shall determine the final placement result and underwriting amount according to the online capital arrival. In principle, the underwriting proportion of the recommendation institution (lead underwriter) shall not exceed 30% of the total issuance, that is, in principle, the maximum underwriting amount is 90 million yuan. When the underwriting ratio exceeds 30% of the total amount of this issuance, the recommendation institution (lead underwriter) and the issuer will negotiate whether to take measures to suspend the issuance; After the approval of the issuer and the CSRC is obtained, the issuer shall take the measures to suspend it in a timely manner and report to the CSRC within the effective period.
3. If an online investor has won the lottery for 3 times but failed to pay in full within 12 consecutive months, it shall not participate in the subscription of online new shares, depositary receipts, convertible bonds and exchangeable corporate bonds within 6 months (calculated according to 180 natural days, including the next day) from the next day of the settlement participant’s latest declaration of abandonment of subscription.
The situation of abandoning subscription shall be judged by investors. The number of times of abandonment of subscription shall be calculated according to the cumulative number of new shares, depositary receipts, convertible bonds and exchangeable corporate bonds actually abandoned by investors; If an investor holds multiple securities accounts and abandons subscription in any one of the securities accounts, the number of times of abandonment shall be calculated cumulatively. The situations of abandonment of subscription occurred in disqualification and cancellation of securities accounts are also included in the statistics.
For the special account for directional asset management and enterprise annuity account of customers of securities companies, if the “account holder’s name” and “valid identity document number” in the registration data of securities accounts are the same, statistics shall be made according to different investors.
Sichuan Kelun Pharmaceutical Co.Ltd(002422) public offering of 300 million yuan of convertible corporate bonds, the preferential placement and online subscription of the original shareholders have ended on March 18, 2022.
According to the announcement of Sichuan Kelun Pharmaceutical Co.Ltd(002422) public offering of convertible corporate bonds (hereinafter referred to as the “issuance announcement”) published on March 16, 2022 (T-2), once published, this announcement shall be deemed to serve the allocated information to all investors participating in the subscription. The results of the issuance and purchase of Kelun convertible bonds are hereby announced as follows:
1、 General situation
The issuance of Kelun convertible bonds is 300 million yuan, and the issuance price is 100 yuan / piece, with a total of 30 million pieces. The priority placement date and online issuance date of the original shareholders are March 18, 2022 (t day).
2、 Priority placement results of original shareholders
The original shareholders gave priority to placing 24062119 pieces of Kelun convertible bonds, totaling 240621190000 yuan, accounting for 80.21% of the total issued this time.
3、 Online subscription results and successful issuance rate of social public investors
A total of 5937880 pieces of Kelun convertible bonds issued online to public investors were finally determined in this issuance, with a total of 59378800000 yuan, accounting for 19.79% of the total issuance, and the online winning rate was 00051215886%.
According to the online subscription data provided by Shenzhen Stock Exchange, the number of valid subscriptions issued online to public investors is 115938245050, the total number of allotments is 11593824505, and the starting and ending numbers are 000000 Ping An Bank Co.Ltd(000001) 011593824505.
The issuer and the recommendation institution (lead underwriter) will organize a lottery ceremony on March 21, 2022 (T + 1). The lottery results will be published in the securities times, Shanghai Securities News, China Securities News and Securities Daily on March 22, 2022 (T + 2), and on Juchao information network (www.cn. Info. Com. CN.) Make an announcement on the Internet. Investors shall confirm the number of convertible bonds to be subscribed according to the winning lot number. Each winning lot number can only subscribe for 10 pieces (i.e. 1000 yuan) of Karen convertible bonds.
4、 Placement results
Category effective subscription quantity (piece) actual allocated quantity (piece) winning rate / placing proportion
Original shareholder 2406211924062119100.00%
Online social public investors 11593824505059378800 00051215886%
Total 11596230716929999999-
Note: as stipulated in the issuance announcement, one subscription unit will be allocated to the original shareholders in priority, and one subscription unit will be allocated to every 10 online subscriptions. Therefore, one balance will be underwritten by the sponsor (lead underwriter).
5、 Time to market
The listing time of Kelun convertible bonds issued this time will be announced separately.
6、 Documents for future reference
For the general information of this offering, please refer to the issuance announcement published in the securities times, Shanghai Securities News, China Securities News and Securities Daily on March 16, 2022 (T-2). Investors can also go to http://www.cn.info.com.cn.) Query the full text of the prospectus and relevant information about the offering.
7、 Contact information of issuer and sponsor (lead underwriter)
(I) issuer
Name: Sichuan Kelun Pharmaceutical Co.Ltd(002422)
Legal representative: Liu Chuangxin
Contact: Feng Hao
Registered address: NanEr Road, Xindu Satellite City Industrial Development Zone, Chengdu, Sichuan
Tel: 02882860678
Fax: 02886132515
(II) recommendation institution (lead underwriter)
Name: Changjiang Securities Company Limited(000783) underwriting sponsor Co., Ltd
Legal representative: Wang Chengjun
Contact: capital market department
Registered address: 28th floor, No. 1198 Century Avenue, China (Shanghai) pilot Free Trade Zone
Tel.: 02161118537
Fax: 02161118973
Issuer: Sichuan Kelun Pharmaceutical Co.Ltd(002422) sponsor (lead underwriter): Changjiang Securities Company Limited(000783) underwriting sponsor Co., Ltd. March 21, 2022
Issuer: Sichuan Kelun Pharmaceutical Co.Ltd(002422) mm / DD / yyyy (this page has no text and is the seal page of the announcement on the success rate of online issuance of Sichuan Kelun Pharmaceutical Co.Ltd(002422) public convertible corporate bonds and the results of preferential placement)
Sponsor (lead underwriter): Changjiang Securities Company Limited(000783) underwriting sponsor Co., Ltd. mm / DD / yyyy
